<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesion</z:e> of the esophagus in which <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium is replaced by intestinalized columnar epithelium </plain></SENT>
<SENT sid="1" pm="."><plain>In Korea, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> associated with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is rare compared with that of Western country </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to investigate the immunohistochemical expression of p53 and Ki-67 in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> which had predictive value for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in Korea </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Ninety five patients (43 male and 52 female, median age 44, range 21-75) who have been suspected to have <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> by endoscopic assessment were enrolled in this study </plain></SENT>
<SENT sid="4" pm="."><plain>Alcian blue (pH 2.5) and high ion <z:chebi fb="3" ids="15571,23666">diamine</z:chebi> stain for the evaluation of specialized <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (SIM) and immunohistochemical stain for p53 and Ki-67 were done </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: 57.9% (55/95) of biopsies from the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar lined esophagus</z:e> showed SIM, but no <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>56.4% (31/55) of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> showed sulfomucin positive colonic <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>The p53 expression was observed in 10.9% (6/55) of the patients of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:hpo ids='HP_0000001'>all</z:hpo> of them showed colonic <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Ki-67 labeling index showed no difference significantly </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In Korea, 10.9% of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> had p53 mutation and moreover <z:hpo ids='HP_0000001'>all</z:hpo> of them had colonic <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>Consequently, we expect that these patients have high risk of developing <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and need careful follow-up </plain></SENT>
</text></document>